诚达药业
(301201)
| 流通市值：31.40亿 | | | 总市值：44.76亿 |
| 流通股本：1.09亿 | | | 总股本：1.55亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 445,496,148.82 | 178,463,170.9 | 479,133,966.54 | 942,397,244.75 |
| 应收票据及应收账款 | 129,852,780.29 | 94,969,047.08 | 73,246,021.66 | 104,410,746.63 |
| 其中：应收票据 | 20,774.75 | 291,272.04 | 1,688,200 | 3,782,995 |
| 应收账款 | 129,832,005.54 | 94,677,775.04 | 71,557,821.66 | 100,627,751.63 |
| 应收款项融资 | - | 1,771,823.96 | - | - |
| 预付款项 | 18,963,808.57 | 3,457,722.4 | 52,885,125.78 | 30,573,371.16 |
| 其他应收款合计 | 631,832.92 | 520,028.06 | 474,981.04 | 336,231 |
| 存货 | 127,034,089.95 | 135,271,478.91 | 128,366,651.49 | 117,462,582.36 |
| 合同资产 | 1,009,275.25 | 1,009,275.25 | - | - |
| 其他流动资产 | 41,037,037.18 | 42,049,089.26 | 24,131,899.34 | 14,093,994.93 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,409,157,168.35 | 1,415,163,656.14 | 1,463,203,712.55 | 1,518,058,580.33 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 7,410,000 | 7,410,000 | 30,000,000 | 30,000,000 |
| 投资性房地产 | 46,255,384.92 | 46,541,078.49 | 46,826,772.06 | 47,112,465.63 |
| 固定资产 | 761,363,322.57 | 770,793,701.82 | 453,728,377.98 | 458,343,638.86 |
| 在建工程 | 66,164,257.16 | 101,455,413.56 | 253,210,454.71 | 199,285,985 |
| 无形资产 | 36,128,816.32 | 36,513,840.37 | 33,035,642.97 | 33,306,858.36 |
| 长期待摊费用 | 40,650,124.91 | 44,118,487.77 | 35,751,760.2 | 37,928,924.64 |
| 递延所得税资产 | 8,378,015.38 | 8,061,540.97 | 3,876,534.02 | 3,745,883.55 |
| 其他非流动资产 | 13,942,218.61 | 6,402,284.96 | 75,755,317.59 | 79,066,690.9 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 980,292,139.87 | 1,021,296,347.94 | 932,184,859.53 | 888,790,446.94 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,389,449,308.22 | 2,436,460,004.08 | 2,395,388,572.08 | 2,406,849,027.27 |
| 流动负债: | | | | |
| 短期借款 | - | - | - | 600,000 |
| 应付票据及应付账款 | 138,345,655.74 | 189,227,095.01 | 146,386,538.8 | 133,953,086.86 |
| 其中：应付票据 | 15,244,841.2 | 23,265,564.2 | 22,925,615.7 | 19,041,318.8 |
| 应付账款 | 123,100,814.54 | 165,961,530.81 | 123,460,923.1 | 114,911,768.06 |
| 预收款项 | 110,106.12 | 16,283 | 101,570 | 103,064 |
| 合同负债 | 2,829,944.3 | 2,785,479.67 | 4,828,188.79 | 13,892,919.8 |
| 应付职工薪酬 | 7,133,602.78 | 5,032,448.89 | 1,133,000.58 | 2,541,711.54 |
| 应交税费 | 464,627.73 | 4,767,418.98 | 447,561.32 | -2,243,658.42 |
| 其他应付款合计 | 4,332,937.42 | 4,674,483.24 | 4,840,165.55 | 4,048,025.42 |
| 一年内到期的非流动负债 | - | 62,314.29 | - | - |
| 其他流动负债 | - | 194,136.62 | - | - |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 153,216,874.09 | 206,759,659.7 | 157,737,025.04 | 152,895,149.2 |
| 非流动负债: | | | | |
| 长期借款 | 88,197,679.9 | 80,118,379.9 | - | - |
| 递延收益 | 2,312,618.48 | 2,511,161.66 | 2,709,704.98 | 2,908,248.16 |
| 递延所得税负债 | 1,361,133.46 | 1,377,218.92 | 1,933,423.44 | 1,821,411.48 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 91,871,431.84 | 84,006,760.48 | 4,643,128.42 | 4,729,659.64 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 245,088,305.93 | 290,766,420.18 | 162,380,153.46 | 157,624,808.84 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 154,713,824 | 154,713,824 | 154,713,824 | 154,713,824 |
| 资本公积 | 1,693,936,183.68 | 1,693,936,183.68 | 1,693,874,093.68 | 1,693,687,823.68 |
| 减:库存股 | 57,073,347.67 | 57,073,347.67 | 57,073,347.67 | 55,278,100.14 |
| 其他综合收益 | -19,201,500 | -19,201,500 | - | - |
| 盈余公积 | 58,491,579.28 | 58,491,579.28 | 55,907,973.27 | 55,907,973.27 |
| 未分配利润 | 310,784,184.13 | 312,184,166.11 | 383,264,221.12 | 398,361,493.36 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,141,650,923.42 | 2,143,050,905.4 | 2,230,686,764.4 | 2,247,393,014.17 |
| 少数股东权益 | 2,710,078.87 | 2,642,678.5 | 2,321,654.22 | 1,831,204.26 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,144,361,002.29 | 2,145,693,583.9 | 2,233,008,418.62 | 2,249,224,218.43 |
| 负债和股东权益合计 | 2,389,449,308.22 | 2,436,460,004.08 | 2,395,388,572.08 | 2,406,849,027.27 |
| 公告日期 | 2025-04-25 | 2025-04-25 | 2024-10-29 | 2024-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |